Clinigen Group (CLIN)

 

Latest News

Director Deals - Clinigen Group (CLIN)

Peter George, Chief Executive Officer, sold 500,000 shares in the company on the 22nd June 2017 at a price of 875.00p. The ...

Director/PDMR Shareholding

RNS Number: 0003J Clinigen Group plc 23 June 2017 23 June 2017 Director's Share Dealing Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services group, announces that it was notified on 22 June 2017 that the following transactions took place on 22 June 2017. Peter George, Non-Executive Director, sold 500,000 ordinary shares...

Issue of Equity

RNS Number: 7694I Clinigen Group plc 22 June 2017 22 June 2017 Issue of Equity Clinigen Group plc (the "Group", AIM: CLIN) announces that it has made an application for the admission to trading on AIM of 1,676 ordinary shares of 0.1 pence each in the Group (the "New Ordinary Shares"), which have been issued to satisfy the exercise of share options and rank p...

Clinigen options exercised

Clinigen Group has issued 13,436 ordinary shares following the exercise of share options. At 9:34am: (LON:CLIN) Clinigen G...

All News

DateHeadlineSource
23-06-17Director Deals - Clinigen Group (CLIN)StockMarketWire
23-06-17Director/PDMR ShareholdingRNS
22-06-17Issue of EquityRNS
07-06-17Clinigen options exercised StockMarketWire
07-06-17Issue of EquityRNS
01-06-17Director/PDMR ShareholdingRNS
22-05-17Clinigen achieves positive Cardioxane CHMP opinionStockMarketWire
22-05-17Clinigen achieves positive Cardioxane CHMP opinionRNS
18-05-17Fund manager's favourite small-cap pharma shares Interactive Investor
11-05-17Clinigen and TESARO launch European MA programmeStockMarketWire
11-05-17Clinigen and TESARO launch European MA ProgramRNS
09-05-17Director Deals - Clinigen Group (CLIN)StockMarketWire
03-05-17Holding(s) in CompanyRNS
25-04-17Clinigen and Onxeo initiate MA programme in EuropeRNS
21-04-17Holding(s) in CompanyRNS
04-04-17Broker Forecast - Numis issues a broker note on Clinigen GroupStockMarketWire
16-03-17Clinigen and Diurnal partner for MA programmeStockMarketWire
16-03-17Clinigen and Diurnal partner for MA programmeRNS
16-03-17Launch of a European Patient Access programmeRNS
15-03-17Clinigen hikes divi as gross profits rise StockMarketWire
15-03-17Half-year ReportRNS
10-03-17First-in-class Fycompa? approved in South AfricaRNS
09-03-17Holding(s) in CompanyRNS
28-02-17Halaven? (eribulin) launches in South AfricaRNS
24-02-17Broker Forecast - Peel Hunt issues a broker note on Clinigen GroupStockMarketWire
22-02-17Notification of half year results dateRNS
25-01-17Broker Forecast - Stifel issues a broker note on Clinigen GroupStockMarketWire
25-01-17Broker Forecast - N+1 Singer issues a broker note on Clinigen GroupStockMarketWire
25-01-17Clinigen gross profit up 34%StockMarketWire
25-01-17HY trading updateRNS
17-01-17Clinigen initiates programme for TESARO inhibitorStockMarketWire
17-01-17Clinigen initiates program for TESARO's niraparibRNS
13-01-17Change of Joint BrokerRNS
09-01-17Clinigen and Cumberland enter agreement for TotectStockMarketWire
09-01-17Clinigen and Cumberland enter agreement for TotectRNS
15-12-16Clinigen signs agreement with BioQ PharmaRNS
01-12-16Clinigen collaborates with Eisai in South AfricaStockMarketWire
01-12-16Clinigen collaborates with Eisai in South AfricaRNS
14-11-16Director Deals - Clinigen Group (CLIN)StockMarketWire
14-11-16Director/PDMR ShareholdingRNS

RSS feeds

  • Editorial news feed for LSE:CLIN Editorial
  • Regulatory news feed for LSE:CLIN Regulatory